Skip to content
OpenCapital
Get started

Pacira BioSciences, Inc. PCRX Business Segments — Adjusted selling and marketing

Similar metrics at other companies

Open Text logo
OTEXReportable Segment — Adjusted sales and marketing
$274.3M+8.3%
UiPath logo
PATHReportable Segment — Adjusted sales and marketing
$148.6M+11.6%
Calix logo
CALXReportable Segment — Selling And Marketing Operating Expense, Adjusted
$56.84M+10.2%
nCino, Inc. logo
NCNOReportable Segment — Adjusted sales and marketing expense
$26.88M+4.7%
Five9 logo
FIVNReportable Segment — Adjusted Sales and Marketing Expense
$70.92M-0.5%
Dynatrace logo
DTReportable Segment — Adjusted sales and marketing expenses
$160.1M+13.8%

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$942.78M-14.5%
Enterprise value$1.21B+2.6%
P/E183.5×—
P/S1.3×-0.3×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%—
Net margin0.7%—
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%—
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept pcrx:SellingAndMarketingAdjusted.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s business segments — adjusted selling and marketing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s business segments — adjusted selling and marketing?
Pacira BioSciences, Inc. (PCRX) reported business segments — adjusted selling and marketing of $58.17M in Q1 2026.
How has Pacira BioSciences, Inc.'s business segments — adjusted selling and marketing changed year-over-year?
Pacira BioSciences, Inc.'s business segments — adjusted selling and marketing increased by 4.7% year-over-year, from $55.57M to $58.17M.
What is the long-term trend for Pacira BioSciences, Inc.'s business segments — adjusted selling and marketing?
Over 3 years (2022 to 2025), Pacira BioSciences, Inc.'s business segments — adjusted selling and marketing has grown at a 16.0% compound annual growth rate (CAGR), from $145M to $226.62M.
What does business segments — adjusted selling and marketing mean?
Includes the adjusted costs associated with promoting, selling, and distributing the segment's products, excluding non-recurring items. It measures the investment intensity required to maintain or grow market share and brand awareness for the segment.